Xylazine Drives 900% Surge in Blood Infections

Scripps Research developed a vaccine to counteract the effects of xylazine, offering potential relief for overdose symptoms. Research has linked the surge in group A staph infections to the introduction of xylazine in the street supply of drugs, highlighting injection drug use and homelessness as risk factors. The majority of patients with blood infections presented with severe skin wounds.